Gerresheimer Opens New High-tech Production Facility For Pharma Glass In China 1

< BACK TO MANUFACTURING starstarstarstarstar   Industry - Manufacturing Press Release
29th May 2009, 10:44pm - Views: 878





Science Information Technology Gerresheimer AG 1 image







Gerresheimer Opens new High-Tech Production Facility for Pharma Glass in

China


DÜSSELDORF, May 27 /PRNewswire-AsiaNet/ --


    - Now Seven Plants in China


    The Gerresheimer Group today opened a new plant for

pharmaceutical glass packaging in China. The high-tech production

facility constructed in Danyang (Jiangsu Province) covers 16,000 square

meters. Specializing in high-quality pharmaceutical vials and cartridges

for injection systems it serves the pharma & life science industry on

both a local and international level. Dr. Axel Herberg, CEO of

Gerresheimer AG, describes the investment as a very important strategic

step for further business expansion in Asia. In China, Gerresheimer now

operates seven production plants for highly specific glass and plastic

products.


    The new facility belongs to Gerresheimer Shuangfeng, a Chinese

subsidiary of the Group, which was acquired in 2006 and now already has

production plants in three locations with a total of more than 150

production lines. With investment in future-oriented technologies and a

high-quality range of vials, ampoules and cartridges, it has in just a

few years developed into the market leader in China, said Dr. Max Raster,

member of the Management Board of Gerresheimer AG with responsibility for

the Tubular Glass Division, at the opening ceremony on May 29, 2009.


    "'Top quality produced in China' is the corporate philosophy

here which binds us directly to the ambitious objectives for development

of the local economy and the Jiangsu region," Raster said. At the gala

opening he joined Chao Xingsong, the Managing Director of Gerresheimer

Danyang, in welcoming representatives from the world of politics and the

administration as well as a large number of national and international

customers who clearly showed they were impressed by the high technical

standard.


    The state-of-the-art plant in the up-and-coming city with

800,000 inhabitants just 250 kilometers to the west of Shanghai is of

outstanding strategic importance for the globally active Gerresheimer

Group. A key area of focus for it is the rapidly growing Asian pharma

market with its constantly rising quality demands in terms of packaging

and drug delivery. In the unanimous assessment of experts, China is

already the fifth largest pharma market in the world.


    In parallel with its local status as a technology advanced

pharma glass plant the Danyang facility offers ideal conditions and

flexible expansion possibilities to enable it to supply customers with

high-quality specialist products in neighboring Asian countries and other

market regions as well. "We work at the highest level of internationally

recognized quality standards," Raster stresses. The technical production

processes are for example monitored by in-line camera systems - a product

control process which is by no means universal industry practice in China

or elsewhere. The clean-room concept also reflects the latest development

status.

Science Information Technology Gerresheimer AG 2 image


    In Danyang, which has for years been regarded as a highly

attractive industrial location for foreign investors in particular,

Gerresheimer Shuangfeng also has a second production plant exclusively

for pharmaceutical vials. In addition, the company manufactures vials and

ampoules in Zhenjiang, also in the Province of Jiangsu. Four other plants

of the Gerresheimer Group also manufacture in the country. In total,

Gerresheimer employs around 1,500 people in China.


    About Gerresheimer


    Gerresheimer employs around 10,000 people in 42 locations in

Europe, America and Asia. In the financial year 2008, worldwide sales

totalled EUR1.06bn. The product portfolio ranges from pharmaceutical

vials made of glass and plastic through to complex drug-delivery systems

for the pharma & life science industry. These include sterile syringes,

inhalers and other system-based approaches for safe dosage and

application of medications. The Group enjoys a leading position in

markets which are characterised by high technical and regulatory

barriers.


    Contact Press


    Burkhard Lingenberg

    Director Corporate Communication & Marketing

    Phone +49-211-6181-250

    Fax +49-211 6181-241

    e-mail b.lingenberg@gerresheimer.com


    Contact Investor Relations


    Anke Linnartz

    Director Corporate Investor Relations

    Phone +49-211-6181-314

    Fax +49-211-6181-121

    e-mail a.linnartz@gerresheimer.com


    SOURCE: Gerresheimer AG








news articles logo NEWS ARTICLES
Contact News Articles |Remove this article